ESTRO Brachytherapy for Prostate Cancer 2018

• The first survey identified 92 medical events:

• 57 were due to a dose less than 80% of the prescribed dose ( underdose ),

• 35 were due to a dose to an organ or tissue out of the treatment site that exceeded the accepted limit. ( Overdoses of rectum, bladder wall or prostate surrounding tissues)